Isavuconazole in Hematological Patients: Results of a Real-Life Multicentre Observational Seifem Study

Invasive fungal diseases (IFDs) remain a major clinical issue in patients with hematological malignancies (HMs). To confirm the efficacy and safety of the new azole isavuconazole (ISV) in a clinical care setting, we planned a multicenter retrospective study; we collected data on all possible/probabl...

Descripción completa

Detalles Bibliográficos
Autores principales: Cattaneo, Chiara, Busca, Alessandro, Gramegna, Doriana, Farina, Francesca, Candoni, Anna, Piedimonte, Monica, Fracchiolla, Nicola, Pagani, Chiara, Principe, Maria Ilaria Del, Tisi, Maria Chiara, Offidani, Massimo, Fanci, Rosa, Ballanti, Stelvio, Spolzino, Angelica, Criscuolo, Marianna, Marchesi, Francesco, Nadali, Gianpaolo, Delia, Mario, Picardi, Marco, Sciumé, Margherita, Mancini, Valentina, Olivieri, Attilio, Tumbarello, Mario, Rossi, Giuseppe, Pagano, Livio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6924559/
https://www.ncbi.nlm.nih.gov/pubmed/31976489
http://dx.doi.org/10.1097/HS9.0000000000000320

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6924559/
https://www.ncbi.nlm.nih.gov/pubmed/31976489
http://dx.doi.org/10.1097/HS9.0000000000000320

Ejemplares similares